Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Texas A&M University System has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners but are both located in 1 distinct art unit. Jason Y. Chong is the busiest examiner, managing 1 pending action. Since both actions are in the same art unit, the university may encounter consistent procedural requirements despite working with 2 different examiners.
The presence of 2 distinct examiners for 2 pending office actions ensures that each case receives an independent technical review. Practitioners should focus on the standards of the 1 art unit that manages both pending matters. Because Chong is responsible for 1 pending action, he is one of two key examiners for the university's current biotechnology filings. This concentration in a single art unit suggests a focused technical scope for the pending applications. Managing the 2 pending actions requires addressing the individual feedback of both examiners within their shared art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHONG, JASON Y | 1 | 73.3% | +18.1% |
| HAVLIN, ROBERT H | 1 | 51.5% | +28.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19015974 | FOAMING SYSTEM FOR EFFICIENT PLASMA PROCESSING OF HEAVY HYDROCARBON | CHONG, JASON Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18168409 | SARS-COV-2 MAIN PROTEASE INHIBITORS | HAVLIN, ROBERT H | 45d overdue |
| 19015974 | FOAMING SYSTEM FOR EFFICIENT PLASMA PROCESSING OF HEAVY HYDROCARBON | CHONG, JASON Y | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19015974 | FOAMING SYSTEM FOR EFFICIENT PLASMA PROCESSING OF HEAVY HYDROCARBON | CHONG, JASON Y | — | §102§103 | Non-Final OA | — | Pending | Jan 10, 2025 |
| 18168409 | SARS-COV-2 MAIN PROTEASE INHIBITORS | HAVLIN, ROBERT H | 1626 | §103 | Final Rejection | 45d overdue | Pending | Feb 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial